These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27526129)

  • 1. Molecular Imaging of Tumor Hypoxia: Existing Problems and Their Potential Model-Based Solutions.
    Shi K; Ziegler SI; Vaupel P
    Adv Exp Med Biol; 2016; 923():87-93. PubMed ID: 27526129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of FMISO [F
    Asgari H; Soltani M; Sefidgar M
    Microvasc Res; 2018 Jul; 118():20-30. PubMed ID: 29408401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data.
    Kelly CJ; Brady M
    Phys Med Biol; 2006 Nov; 51(22):5859-73. PubMed ID: 17068369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matching the reaction-diffusion simulation to dynamic [
    Shi K; Bayer C; Gaertner FC; Astner ST; Wilkens JJ; Nüsslin F; Vaupel P; Ziegler SI
    Physiol Meas; 2017 Feb; 38(2):188-204. PubMed ID: 28055983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation of tissue activity curves of (64)Cu-ATSM for sub-target volume delineation in radiotherapy.
    Dalah E; Bradley D; Nisbet A
    Phys Med Biol; 2010 Feb; 55(3):681-94. PubMed ID: 20071761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.
    Thorwarth D; Eschmann SM; Paulsen F; Alber M
    Phys Med Biol; 2005 May; 50(10):2209-24. PubMed ID: 15876662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.
    Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Thorwarth D
    Phys Med Biol; 2012 Mar; 57(6):1675-84. PubMed ID: 22398239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of necrosis, acute hypoxia and chronic hypoxia in
    Warren DR; Partridge M
    Phys Med Biol; 2016 Dec; 61(24):8596-8624. PubMed ID: 27880734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Hypoxia: Causative Mechanisms, Microregional Heterogeneities, and the Role of Tissue-Based Hypoxia Markers.
    Vaupel P; Mayer A
    Adv Exp Med Biol; 2016; 923():77-86. PubMed ID: 27526128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.
    Riedl CC; Brader P; Zanzonico P; Reid V; Woo Y; Wen B; Ling CC; Hricak H; Fong Y; Humm JL
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):39-46. PubMed ID: 17786438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
    Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
    Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.
    Rajendran JG; Krohn KA
    Semin Nucl Med; 2015 Mar; 45(2):151-62. PubMed ID: 25704387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
    Peeters SG; Zegers CM; Lieuwes NG; van Elmpt W; Eriksson J; van Dongen GA; Dubois L; Lambin P
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):351-9. PubMed ID: 25491505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modeling of
    Abazari MA; Soltani M; Eydi F; Rahmim A; Kashkooli FM
    Biomed Phys Eng Express; 2024 Sep; 10(6):. PubMed ID: 39214120
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor Oxygenation Status: Facts and Fallacies.
    Vaupel P; Mayer A
    Adv Exp Med Biol; 2017; 977():91-99. PubMed ID: 28685432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia.
    Daşu A; Toma-Daşu I; Karlsson M
    Phys Med Biol; 2003 Sep; 48(17):2829-42. PubMed ID: 14516104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study.
    Wack LJ; Mönnich D; van Elmpt W; Zegers CM; Troost EG; Zips D; Thorwarth D
    Acta Oncol; 2015; 54(9):1370-7. PubMed ID: 26203928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.
    Bejot R; Kersemans V; Kelly C; Carroll L; King RC; Gouverneur V; Elizarov AM; Ball C; Zhang J; Miraghaie R; Kolb HC; Smart S; Hill S
    Nucl Med Biol; 2010 Jul; 37(5):565-75. PubMed ID: 20610161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.